Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 204S204 trades$51.20M
Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
TSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
MTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
ADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 5 | Sroka DianaDirector |  SOUNSOUNDHOUND AI, INC.Open-market sale · 10b5-1 plan | SELL | $17K 1,343 sh | Nov 14, 2025 |
| 5 | Charlton Rebecca LSVP, Controller & CAO |  BKRBaker Hughes CoOpen-market sale · 10b5-1 plan | SELL | $13K 278 sh | Nov 14, 2025 traded Nov 13, 2025 |
| 4 | Greenstreet YvonneDirector, Chief Executive Officer |  ALNYALNYLAM PHARMACEUTICALS, INC.Open-market sale · 10b5-1 plan | SELL | $1000K 2,218 sh | Nov 14, 2025 traded Nov 13, 2025 |
| 4 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $724K 1,599 sh | Nov 14, 2025 traded Nov 13, 2025 |
| 4 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $769K 1,702 sh | Nov 14, 2025 traded Nov 13, 2025 |
| 4 | Hao XinyanChief Operating Officer |  GCTGigaCloud Technology IncOpen-market sale · 10b5-1 plan | SELL | $768K 24.6K sh | Nov 14, 2025 traded Nov 12, 2025 |
| 4 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $293K 654 sh | Nov 14, 2025 traded Nov 13, 2025 |
| 4 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $665K 1,477 sh | Nov 14, 2025 traded Nov 13, 2025 |
| 4 | Hao XinyanChief Operating Officer | GCTGigaCloud Technology Inc Open-market sale · 10b5-1 plan | SELL | $913K 30.0K sh | Nov 14, 2025 traded Nov 14, 2025 |
| 4 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $455K 1,013 sh | Nov 14, 2025 traded Nov 13, 2025 |
| 4 | Hao XinyanChief Operating Officer | GCTGigaCloud Technology Inc Open-market sale · 10b5-1 plan | SELL | $281K 8,568 sh | Nov 14, 2025 traded Nov 13, 2025 |
| 4 | Hao XinyanChief Operating Officer | GCTGigaCloud Technology Inc Open-market sale · 10b5-1 plan | SELL | $683K 21.4K sh | Nov 14, 2025 traded Nov 13, 2025 |
| 4 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $400K 881 sh | Nov 14, 2025 traded Nov 13, 2025 |
| 1 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $89K 195 sh | Nov 14, 2025 traded Nov 13, 2025 |
| 1 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $119K 261 sh | Nov 14, 2025 traded Nov 13, 2025 |
| 1 | Hao XinyanChief Operating Officer | GCTGigaCloud Technology Inc Open-market sale · 10b5-1 plan | SELL | $176K 5,446 sh | Nov 14, 2025 traded Nov 12, 2025 |
| 57 | Levy Adam ScottCFO and Secretary |  MLYSMineralys Therapeutics, Inc.Open-market sale | SELL | $1.53M 32.7K sh | Nov 13, 2025 traded Nov 11, 2025 |
| 54 | Vivas EduardoDirector | APPAppLovin Corp Open-market sale | SELL | $12.58M 19.2K sh | Nov 13, 2025 traded Nov 10, 2025 |
| 54 | Vivas EduardoDirector | APPAppLovin Corp Open-market sale | SELL | $13.50M 20.7K sh | Nov 13, 2025 traded Nov 10, 2025 |
| 54 | Vivas EduardoDirector | APPAppLovin Corp Open-market sale | SELL | $11.38M 17.5K sh | Nov 13, 2025 traded Nov 10, 2025 |
| 54 | Vivas EduardoDirector | APPAppLovin Corp Open-market sale | SELL | $20.10M 30.9K sh | Nov 13, 2025 traded Nov 10, 2025 |
| 54 | Vivas EduardoDirector | APPAppLovin Corp Open-market sale | SELL | $17.44M 26.8K sh | Nov 13, 2025 traded Nov 10, 2025 |
| 54 | Karydas DaphneDirector | MLYSMineralys Therapeutics, Inc. Open-market sale | SELL | $463K 10.1K sh | Nov 13, 2025 traded Nov 13, 2025 |
| 54 | Gold Alexander MDirector | MLYSMineralys Therapeutics, Inc. Open-market sale | SELL | $424K 10.0K sh | Nov 13, 2025 traded Nov 11, 2025 |
| 53 | Levy Adam ScottCFO and Secretary | MLYSMineralys Therapeutics, Inc. Open-market sale | SELL | $1.79M 38.9K sh | Nov 13, 2025 traded Nov 11, 2025 |
| 51 | Vivas EduardoDirector | APPAppLovin Corp Open-market sale | SELL | $6.14M 9,392 sh | Nov 13, 2025 traded Nov 10, 2025 |
| 51 | Gold Alexander MDirector | MLYSMineralys Therapeutics, Inc. Open-market sale | SELL | $235K 5,000 sh | Nov 13, 2025 traded Nov 11, 2025 |
| 51 | Vivas EduardoDirector | APPAppLovin Corp Open-market sale | SELL | $1.43M 2,201 sh | Nov 13, 2025 traded Nov 10, 2025 |
| 51 | Vivas EduardoDirector | APPAppLovin Corp Open-market sale | SELL | $1.55M 2,399 sh | Nov 13, 2025 traded Nov 10, 2025 |
| 51 | Karydas DaphneDirector | MLYSMineralys Therapeutics, Inc. Open-market sale | SELL | $226K 4,885 sh | Nov 13, 2025 traded Nov 13, 2025 |
| 51 | Vivas EduardoDirector | APPAppLovin Corp Open-market sale | SELL | $2.81M 4,367 sh | Nov 13, 2025 traded Nov 10, 2025 |
| 51 | Vivas EduardoDirector | APPAppLovin Corp Open-market sale | SELL | $1.42M 2,194 sh | Nov 13, 2025 traded Nov 10, 2025 |
| 51 | Vivas EduardoDirector | APPAppLovin Corp Open-market sale | SELL | $1.76M 2,684 sh | Nov 13, 2025 traded Nov 10, 2025 |
| 51 | Vivas EduardoDirector | APPAppLovin Corp Open-market sale | SELL | $6.24M 9,619 sh | Nov 13, 2025 traded Nov 10, 2025 |
| 50 | Gold Alexander MDirector | MLYSMineralys Therapeutics, Inc. Open-market sale | SELL | $593K 12.7K sh | Nov 13, 2025 traded Nov 13, 2025 |
| 50 | Gu PaulDirector, Chief Technology Offier |  UPSTUpstart Holdings, Inc.Open-market purchase | BUY | $3.14M 80.0K sh | Nov 13, 2025 traded Nov 11, 2025 |
| 49 | Congleton JonDirector, Chief Executive Officer | MLYSMineralys Therapeutics, Inc. Open-market sale | SELL | $5.15M 112.3K sh | Nov 13, 2025 traded Nov 11, 2025 |
| 48 | Vivas EduardoDirector | APPAppLovin Corp Open-market sale | SELL | $315K 480 sh | Nov 13, 2025 traded Nov 10, 2025 |
| 48 | Vivas EduardoDirector | APPAppLovin Corp Open-market sale | SELL | $988K 1,535 sh | Nov 13, 2025 traded Nov 10, 2025 |
| 48 | Dewan SameerSenior Vice President |  GGenpact LTDOpen-market sale | SELL | $1.19M 26.5K sh | Nov 13, 2025 traded Nov 11, 2025 |